HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Li Selected Research

Cavernous Hemangioma (Cavernous Angioma)

11/2021Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage.
1/2021A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
1/2019Biomarkers of cavernous angioma with symptomatic hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Li Research Topics

Disease

1431Neoplasms (Cancer)
12/2022 - 03/2002
264Inflammation (Inflammations)
12/2022 - 12/2004
240Infections
06/2022 - 04/2003
227Neoplasm Metastasis (Metastasis)
07/2022 - 05/2002
203Breast Neoplasms (Breast Cancer)
07/2022 - 07/2002
181Hepatocellular Carcinoma (Hepatoma)
12/2022 - 04/2003
139Stomach Neoplasms (Stomach Cancer)
12/2022 - 10/2003
139Carcinogenesis
08/2022 - 10/2002
125Hypertension (High Blood Pressure)
04/2022 - 02/2003
111Lung Neoplasms (Lung Cancer)
09/2022 - 07/2003
108Fibrosis (Cirrhosis)
12/2022 - 01/2005
97Alzheimer Disease (Alzheimer's Disease)
07/2022 - 01/2003
97Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 07/2003
93Carcinoma (Carcinomatosis)
04/2022 - 10/2002
92Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 05/2003
86Hypoxia (Hypoxemia)
10/2022 - 03/2002
79Body Weight (Weight, Body)
04/2022 - 04/2004
78Human Influenza (Influenza)
10/2022 - 04/2002
71COVID-19
11/2022 - 01/2020
71Insulin Resistance
07/2022 - 12/2005
70Type 2 Diabetes Mellitus (MODY)
10/2022 - 06/2005
68Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 01/2002
66Stroke (Strokes)
09/2022 - 11/2004
66Adenocarcinoma
01/2022 - 12/2002
65Wounds and Injuries (Trauma)
04/2022 - 12/2004
65Atherosclerosis
01/2022 - 05/2007
62Pain (Aches)
10/2022 - 01/2007
61Reperfusion Injury
07/2022 - 06/2002
60Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 04/2003
58Myocardial Infarction
02/2022 - 01/2002
55Cognitive Dysfunction
11/2022 - 12/2005
54Ischemia
10/2022 - 03/2002
54Leukemia
01/2022 - 12/2004
51Esophageal Squamous Cell Carcinoma
10/2022 - 05/2003
49Sepsis (Septicemia)
12/2022 - 02/2005
48Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022 - 10/2005
48Glioma (Gliomas)
08/2022 - 08/2007
47Brain Ischemia (Cerebral Ischemia)
07/2022 - 02/2005
46Lymphatic Metastasis
01/2022 - 04/2003
43Heart Failure
06/2022 - 01/2003
42Adenocarcinoma of Lung
01/2022 - 12/2002
41Autoimmune Diseases (Autoimmune Disease)
10/2022 - 12/2005
41Pneumonia (Pneumonitis)
10/2022 - 04/2002
41Parkinson Disease (Parkinson's Disease)
05/2022 - 12/2007
41Melanoma (Melanoma, Malignant)
01/2022 - 10/2002
39Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022 - 05/2006
38Obesity
07/2022 - 11/2008
38Infarction (Infarctions)
01/2022 - 01/2002
37Ovarian Epithelial Carcinoma
12/2022 - 04/2003
37Hemorrhage
12/2022 - 02/2009
37Prostatic Neoplasms (Prostate Cancer)
01/2022 - 09/2003
36Colonic Neoplasms (Colon Cancer)
06/2022 - 10/2002

Drug/Important Bio-Agent (IBA)

514Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2002
270Biomarkers (Surrogate Marker)IBA
10/2022 - 02/2005
261Pharmaceutical PreparationsIBA
11/2022 - 01/2004
187Biological ProductsIBA
04/2022 - 08/2003
158CytokinesIBA
10/2022 - 02/2003
145MicroRNAs (MicroRNA)IBA
06/2022 - 04/2010
143Messenger RNA (mRNA)IBA
07/2022 - 05/2003
117Glucose (Dextrose)FDA LinkGeneric
12/2022 - 06/2005
100LipidsIBA
07/2022 - 03/2005
92VaccinesIBA
11/2022 - 11/2002
89DNA (Deoxyribonucleic Acid)IBA
04/2022 - 05/2002
86Long Noncoding RNAIBA
12/2022 - 01/2014
84Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2022 - 03/2002
82Therapeutic UsesIBA
08/2022 - 05/2003
81Small Interfering RNA (siRNA)IBA
01/2022 - 09/2005
78AntigensIBA
12/2021 - 04/2003
74RNA (Ribonucleic Acid)IBA
08/2022 - 04/2002
72Peptides (Polypeptides)IBA
09/2022 - 07/2004
71EnzymesIBA
01/2022 - 07/2002
60Cisplatin (Platino)FDA LinkGeneric
07/2022 - 05/2003
59Interleukin-6 (Interleukin 6)IBA
09/2022 - 05/2003
59Phosphotransferases (Kinase)IBA
01/2022 - 03/2002
57CollagenIBA
03/2022 - 03/2003
55Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2022 - 05/2003
54LigandsIBA
10/2022 - 06/2008
53CateninsIBA
01/2022 - 01/2011
52AntibodiesIBA
01/2022 - 01/2005
50Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 04/2002
47AntioxidantsIBA
10/2022 - 10/2003
47Insulin (Novolin)FDA Link
07/2022 - 03/2004
46LipopolysaccharidesIBA
12/2022 - 03/2006
46Indicators and Reagents (Reagents)IBA
07/2022 - 01/2005
43Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2005
43Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 05/2007
41Estrogens (Estrogen)FDA Link
01/2022 - 07/2002
39Caspase 3 (Caspase-3)IBA
11/2021 - 10/2003
38ErbB Receptors (EGF Receptor)IBA
05/2022 - 03/2005
37Matrix Metalloproteinases (MMPs)IBA
09/2022 - 02/2003
37Transcription Factors (Transcription Factor)IBA
08/2022 - 04/2009
37Amyloid (Amyloid Fibrils)IBA
07/2022 - 01/2007
37CholesterolIBA
07/2022 - 11/2005

Therapy/Procedure

615Therapeutics
12/2022 - 04/2002
239Drug Therapy (Chemotherapy)
06/2022 - 10/2002
80Immunotherapy
07/2022 - 04/2003
54Radiotherapy
06/2022 - 06/2007
38Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 11/2006
37Hyperthermic Intraperitoneal Chemotherapy
01/2022 - 02/2008
36Lasers (Laser)
03/2022 - 01/2004